Provide meeting, programmatic, and administrative support services (mpass) for cdmrp at fort detrick, MD
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- HT942523D0002
- Awardee
-
Leidos, Inc. UEI QLNMVC12KWY3 Part of Leidos Holdings, Inc.
- Awarding agency
-
Defense Health Agency
Department of Defense
- Task orders
- 144 $42,440,525 obligated
Award facts
- Opportunity
-
- Meeting, Programmatic, and Administrative Support Services Pre-Solicitation · W81XWH22R0025 · Posted Aug 16, 2021
- Combined order value
-
- $54,099,830 Current, with exercised options
- $55,621,420 Potential, with all options
- Last date to order 75% complete
- IDV ceiling 42% used
- $102,214,375.31
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Legislative mandates
-
- Walsh-Healey Public Contracts Act FAR subpart 22.6
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
About this IDV
The Defense Health Agency awarded an indefinite-delivery contract to Leidos, Inc. on February 1, 2023, with a ceiling of $102,214,375.31 for meeting, programmatic, and administrative support services (MPASS) for the Congressionally Directed Medical Research Programs at Fort Detrick, Maryland, through January 31, 2028. This is a single-award contract with no set-aside applied.
Work is performed at Fort Detrick, Maryland, with subordinate performance locations including Frederick, Maryland; Reston, Virginia; and Herndon, Virginia. The contract originated from a Defense Health Agency request for information posted August 2021 seeking biomedical research application evaluation support, including scientific and technical personnel to support programmatic review, meetings, administrative tasks, and public affairs functions for CDMRP initiatives. The requirement called for a prime contractor capable of self-performing at least 51 percent of work and maintaining personnel with appropriate security clearances and certifications.
Leidos has issued 47 delivery orders under this IDIQ since May 2025, spanning congressionally directed medical research program portfolios including cancer research (melanoma, prostate, ovarian, pancreatic, lung, breast, kidney, rare cancers), neurological and neurodegenerative disease research (Alzheimer's, Parkinson's, Traumatic Brain Injury and Psychological Health, Epilepsy, Neurofibromatosis), autoimmune and systemic disease research (Lupus, Arthritis, Multiple Sclerosis, Tuberous Sclerosis Complex), musculoskeletal and genetic disorders (Duchenne Muscular Dystrophy, Spinal Cord Injury, Bone Marrow Failure, Reconstructive Transplant), trauma and injury research (Military Burn, Combat Readiness), and specialized health priorities (Tick-Borne Disease, Hearing Restoration, Joint Warfighter Medical Research, Toxic Exposures, Alcohol and Substance Use Disorders, Vision Research). Delivery orders range from $31,805.05 to $3,248,091.53, priced uniformly on a cost-plus-fixed-fee basis, with completion dates between April 2026 and July 2027. Recent task orders include a $3,248,091.53 General Program Support Services order (February 2026), a $877,418.45 Peer Review Cancer Research Program order (May 2026), and a $846,630.25 Peer Review Medical Research Program order (March 2026). Performance occurs at Fort Detrick and regional offices in Frederick and Reston, Virginia, supporting CDMRP program administration and scientific review infrastructure.
Task orders
Show 40 more
Latest 50 of 144 listed here. See the rest on GovTribe.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Change Order | $0 | |
| Other Administrative Action | $0 | |
| Change Order | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Subawards
| Subcontractor | Amount | Awarded |
|---|---|---|
| Ripple Effect Communications, Inc. | $78,450 | |
| Ripple Effect Communications, Inc. | $48,248 | |
| Rose Li And Associates, Inc. | $69,718 | |
| Ripple Effect Communications, Inc. | $87,860 | |
| Vistra Communications, LLC | $66,538 | |
| Rose Li And Associates, Inc. | $48,842 | |
| Ripple Effect Communications, Inc. | $47,535 |
Quick answers
Who was awarded contract HT942523D0002?
HT942523D0002 was awarded to Leidos, Inc. by Defense Health Agency (Department of Defense) on February 1, 2023.
How much is contract HT942523D0002 worth?
Orders under HT942523D0002 have obligated $42,440,525. Their combined current value, with exercised options, is $54,099,830. Their combined potential value, with all options, is $55,621,420. HT942523D0002's own ceiling is $102,214,375.
How many orders have been placed under contract HT942523D0002?
144 orders have been placed under HT942523D0002, the latest on July 14, 2026.
Who can order from contract HT942523D0002?
HT942523D0002 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract HT942523D0002 competed?
The extent of competition for HT942523D0002 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV